A team of UK researchers has developed a pioneering blood test that could enable doctors to detect and monitor lung cancer in ...
A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.
NEW YORK, NY & PHILADELPHIA, PA — New York Gastroenterology Associates, LLP is adopting artificial intelligence–driven ...
Cancer-diagnosing AI models can secretly read patient demographics from pathology slides, leading to biased results.
Analyzing several major pathology AI models designed to diagnose cancer, the researchers found unequal performance in ...
Zacks Investment Research on MSN
3 MedTech stocks poised to gain in 2026 from the AI boom
Per Porsche Consulting’s analysis, artificial intelligence (AI), especially generative AI, is rapidly transforming MedTech ...
FDA expands labels for Roche's PATHWAY HER2 (4B5) test* and VENTANA HER2 Dual ISH DNA Probe Cocktail, which can now be used to identify HER2-positive metastatic breast cancer patients that could be ...
A preprint argues that symptom scores in psychology are not neutral data but active interventions that shape care.
Alzheimer's disease (AD), a leading cause of dementia, exhibits notable heterogeneity in its pathology and clinical expression, suggesting the existence of ...
No significant differences in the safety or effectiveness of tralokinumab were observed by racial subgroup among patients with AD.
Mid-Atlantic Permanente Medical Group shows how trusted data and technology can turn value-based care into better outcomes, ...
Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers from the health system who developed an artificial intelligence (AI) screening tool that significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results